Stockreport

Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting

Genmab A/S - American Depositary Shares  (GMAB) 
PDF   COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB):More than 20 abstracts, including four oral presentations, with new clinical data across lines of th [Read more]